Results 301 to 310 of about 1,543,966 (410)

Feasibility Study of a Novel App‐Based Anxiety Intervention for Autistic People

Autism Research, EarlyView.
ABSTRACT At least 50% of autistic people experience clinically relevant anxiety symptoms. However, reasons for elevated rates of anxiety in autism remain poorly understood and there is a high unmet need for novel and adapted therapies for anxiety that are accessible to autistic people.
Bethany Oakley, Charlotte A. Boatman, Saffron Baldoza, Amy Hearn, Colin Larkworthy, Rachel Kent, Ann Ozsivadjian, Sophie Doswell, Antonia Dittner, Amanda Roestorf, Dhara Rawal, Ben Carter, Emily Simonoff, The Molehill Mountain Advisory Group, Saffron Baldoza, Amy Hearn, Colin Larkworthy, Adrian Judd, Marianne Savage   +18 more
wiley   +1 more source

Effect of oral sesame oil gelatin capsules on episiotomy pain in primiparous women: a triple-blind randomized controlled trial. [PDF]

Matern Health Neonatol Perinatol
Mehrabi Bardar M, Omidi M, Ahmadinezhad GS, Arasteh S, Salari R, Karimi FZ.   +5 more
europepmc   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Spironolactone in end stage renal disease: A story of under'ACHIEVE'ment. [PDF]

J Bras Nefrol
Mathew GG.
europepmc   +1 more source

Hypnotic analgesia and the placebo effect; controlling ischemic pain.

, 1982
Henderikus J. Stam
openalex   +2 more sources

Efficacy and safety of a selective partial agonist for nociception/orphanin‐FQ peptide (NOP) receptors in patients with insomnia disorder

British Journal of Clinical Pharmacology, EarlyView.
Aims Insomnia is a common sleep disorder, affecting up to 20% of the world population and adversely impacting productivity, health, and overall well‐being. Although pharmacologic options exist to treat insomnia, the health‐related quality of life for patients who are prescribed hypnotics is no higher than for those who are not, revealing a significant ...
Garth T. Whiteside, Ellie He, Manjunath S. Shet, Mingyan Zhou, Maha Ahmad, Stephen C. Harris   +5 more
wiley   +1 more source

Automated Retinal Vascular Analysis Reveals Response to Acetazolamide in Idiopathic Intracranial Hypertension. [PDF]

Transl Vis Sci Technol
Woods B, Szanto D, Wang JK, Erekat A, Stern L, Golden A, Garvin MK, Kardon RH, Kupersmith MJ.   +8 more
europepmc   +1 more source

COMPARATIVE EVALUATION OF ORALLY DISINTEGRATING FILM OF ONDANSETRON VERSUS INTRAVENOUS GRANISETRON IN PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING FOLLOWING LAPAROSCOPIC CHOLECYSTECTOMY: A PROSPECTIVE, RANDOMIZED DOUBLE - BLIND PLACEBO - CONTROLLED STUDY

, 2015
Snehalatha Bhashyam, Krishna Prasad P, Sowbhagya Lakshmi B, Anny Naveena   +3 more
openalex   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Pentoxifylline vaginal gel improves sperm motility and vitality in asthenozoospermic males: A randomized, blinded, <i>in vitro</i> study. [PDF]

Front Pharmacol
Trilla C, Navarro L, Rius M, Espinós JJ.   +3 more
europepmc   +1 more source